Literature DB >> 19002894

Identity tests: determination of cell line cross-contamination.

C M Cabrera1, F Cobo, A Nieto, J L Cortés, R M Montes, P Catalina, A Concha.   

Abstract

Cell line cross-contamination is a phenomenon that arises as a result of the continuous cell line culture. It has been estimated that around 20% of the cell lines are misidentified, therefore it is necessary to carry out quality control tests for the detection of this issue. Since cell line cross-contamination discovery, different methods have been applied, such as isoenzyme analysis for inter-species cross-contamination; HLA typing, and DNA fingerprinting using short tandem repeat and a variable number of tandem repeat for intra-species cross-contamination. The cell banks in this sense represent the organizations responsible for guaranteeing the authenticity of cell lines for future research and clinical uses.

Year:  2006        PMID: 19002894      PMCID: PMC3449683          DOI: 10.1007/s10616-006-9013-8

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  30 in total

1.  Distinctive banded marker chromosomes of human tumor cell lines.

Authors:  W A Nelson-Rees; R R Flandermeyer; P K Hawthorne
Journal:  Int J Cancer       Date:  1975-07-15       Impact factor: 7.396

Review 2.  The UK Stem Cell Bank: its role as a public research resource centre providing access to well-characterised seed stocks of human stem cell lines.

Authors:  Lyn Healy; Charles Hunt; Lesley Young; Glyn Stacey
Journal:  Adv Drug Deliv Rev       Date:  2005-11-10       Impact factor: 15.470

3.  Terminology associated with cell, tissue, and organ culture, molecular biology, and molecular genetics. Tissue Culture Association Terminology Committee.

Authors:  W I Schaeffer
Journal:  In Vitro Cell Dev Biol       Date:  1990-01

4.  Acceptability of cell substrates for production of biologicals. Report of a WHO Study Group on Biologicals.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1987

5.  Widespread intraspecies cross-contamination of human tumor cell lines arising at source.

Authors:  R A MacLeod; W G Dirks; Y Matsuo; M Kaufmann; H Milch; H G Drexler
Journal:  Int J Cancer       Date:  1999-11-12       Impact factor: 7.396

6.  Hypervariable 'minisatellite' regions in human DNA.

Authors:  A J Jeffreys; V Wilson; S L Thein
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

Review 7.  Cross-contamination of cells in culture.

Authors:  W A Nelson-Rees; D W Daniels; R R Flandermeyer
Journal:  Science       Date:  1981-04-24       Impact factor: 47.728

Review 8.  Human lymphocyte antigen molecular typing: how to identify the 1250+ alleles out there.

Authors:  John A Gerlach
Journal:  Arch Pathol Lab Med       Date:  2002-03       Impact factor: 5.534

9.  Cell line cross-contamination: how aware are Mammalian cell culturists of the problem and how to monitor it?

Authors:  Gertrude Case Buehring; Elizabeth A Eby; Michael J Eby
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Jul-Aug       Impact factor: 2.416

Review 10.  Microbiological control in stem cell banks: approaches to standardisation.

Authors:  Fernando Cobo; Glyn N Stacey; Charles Hunt; Carmen Cabrera; Ana Nieto; Rosa Montes; José Luis Cortés; Purificación Catalina; Angela Barnie; Angel Concha
Journal:  Appl Microbiol Biotechnol       Date:  2005-10-26       Impact factor: 4.813

View more
  11 in total

1.  Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.

Authors:  Yasufumi Niinaka; Kiyoshi Harada; Masahiro Fujimuro; Masamitsu Oda; Arayo Haga; Misa Hosoki; Narikazu Uzawa; Naoya Arai; Satoshi Yamaguchi; Masashi Yamashiro; Avraham Raz
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

2.  In Vitro Differentiation of Tumor-Associated Macrophages from Monocyte Precursors with Modified Melanoma-Conditioned Medium.

Authors:  Tao Wang; Russel E Kaufman
Journal:  Methods Mol Biol       Date:  2021

3.  Effective Combination Therapies for B-cell Lymphoma Predicted by a Virtual Disease Model.

Authors:  Wei Du; Rebecca Goldstein; Yanwen Jiang; Omar Aly; Leandro Cerchietti; Ari Melnick; Olivier Elemento
Journal:  Cancer Res       Date:  2017-01-27       Impact factor: 12.701

4.  A Multistep Workflow to Evaluate Newly Generated iPSCs and Their Ability to Generate Different Cell Types.

Authors:  Carol X-Q Chen; Narges Abdian; Gilles Maussion; Rhalena A Thomas; Iveta Demirova; Eddie Cai; Mahdieh Tabatabaei; Lenore K Beitel; Jason Karamchandani; Edward A Fon; Thomas M Durcan
Journal:  Methods Protoc       Date:  2021-07-19

5.  Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  J Cancer       Date:  2010-11-29       Impact factor: 4.207

6.  Cell-culture Database: Literature-based reference tool for human and mammalian experimentallybased cell culture applications.

Authors:  Vafa Amirkia; Pan Qiubao
Journal:  Bioinformation       Date:  2012-03-17

Review 7.  Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers.

Authors:  K J Harrington; L J Billingham; T B Brunner; N G Burnet; C S Chan; P Hoskin; R I Mackay; T S Maughan; J Macdougall; W G McKenna; C M Nutting; A Oliver; R Plummer; I J Stratford; T Illidge
Journal:  Br J Cancer       Date:  2011-07-19       Impact factor: 7.640

8.  Rapid detection of low-level HeLa cell contamination in cell culture using nested PCR.

Authors:  Jun Lin; Lin Chen; Wenqian Jiang; Huilian Zhang; Yang Shi; Weiwen Cai
Journal:  J Cell Mol Med       Date:  2018-10-24       Impact factor: 5.310

Review 9.  Bacteriophages as model organisms for virus emergence research.

Authors:  John J Dennehy
Journal:  Trends Microbiol       Date:  2009-09-16       Impact factor: 17.079

10.  Genomic characterization of five commonly used endometrial cancer cell lines.

Authors:  Eric J Devor; Jesus Gonzalez-Bosquet; Kristina W Thiel; Kimberly K Leslie
Journal:  Int J Oncol       Date:  2020-10-21       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.